Borrower record · Q2 2026
LSCS Holdings
As filed by 7 BDCs · period end 30 June 2026Filers label it: Healthcare (3), Life Sciences Tools & Services (2), Pharmaceuticals, Biotechnology & Life Sciences (2)
Seven lenders report $33.0m of LSCS Holdings at Q2 2026, marked at 98.5 cents. One of them has stopped accruing interest on one position.
- Filed fair value
- $33.0m
- 8 funded positions
- Reporting lenders
- 7
- across 8 filed positions
- Aggregate mark
- 98.5c
- cost filed on all 8 positions
- Median spread
- 450bp
- over SOFR, 6 tranches
- Maturities to
- 2032
- earliest February 2032
- Periods on record
- 5
- first filed Q2 2025
How this total is counted
- Every figure above is the sum of 8 funded positions filed by 7 BDCs, each one cited below.
- Counted from the Q2 2026 filings imported for this build, the latest of them filed 20 August 2026. A schedule filed after that date is not in these figures and will appear when the property is rebuilt.
Pricing as filed
6 floating tranches · SOFR450bp on all 6 floating tranches — every filer reports the same spread.
Capital structure
Bars show position counts. All 8 funded positions carry a filed seniority.
Rate structure
Floating, on all 6 positions whose interest type a filer disclosed.
2 of 8 funded positions carry no filed interest type.
Maturity profile
6 of 8 funded positions dated · counts only5.7 years to maturity, weighted by fair value across the 6 dated positions.
Where the lenders disagree
7 filers disclosed a costLender marks on the same debt differ by up to 8.1c.
Credit flags
Not in the filings
- No sector. The filers' industry labels for LSCS Holdings do not agree at NAICS sector level, so the ones two or more of them filed are shown above as filed.
- No values on the capital structure — position counts only. With 7 lenders reporting, splitting the total along that dimension would give up a per-lender figure that sits behind the gate.
- No period-by-period totals. Different lenders reported each of the 5 periods on record, so the movement between them would be a change in who filed, not in the borrower.
- No maturity on 2 of 8 funded positions. Undated is left undated, not assumed.
Sign up for free
Who holds it, and where they mark it.
7 lenders hold the same credit and mark it differently. Behind the gate, one row each — for this borrower and for every other one on this site, free and with no limit on how many you read.
- The spread between the highest and lowest lender mark
- Quarter-on-quarter movement across 5 periods
- Which lender is on non-accrual, and which are not
- The 10-Q or 10-K behind every row, by accession number
Every filing behind this page
7 filers · Q2 2026| Filer | CIK | Form | Period | Filed | Accession |
|---|---|---|---|---|---|
| Antares Private Credit Fund | 0001976336 | 10-Q | 2026-06-30 | 2026-08-13 | 0001193125-26-349158 |
| Antares Strategic Credit Fund | 0001993402 | 10-Q | 2026-06-30 | 2026-08-13 | 0001193125-26-349216 |
| Crescent Capital BDC, Inc. (CCAP) | 0001633336 | 10-Q | 2026-06-30 | 2026-08-10 | 0001193125-26-342351 |
| MSD Investment Corp. | 0001849894 | 10-Q | 2026-06-30 | 2026-08-14 | 0001193125-26-352436 |
| New Mountain Guardian IV BDC, L.L.C. | 0001925531 | 10-Q | 2026-06-30 | 2026-08-11 | 0001925531-26-000014 |
| New Mountain Guardian IV Income Fund, L.L.C. | 0001976719 | 10-Q | 2026-06-30 | 2026-08-12 | 0001976719-26-000020 |
| New Mountain Private Credit Fund | 0002037804 | 10-Q | 2026-06-30 | 2026-08-11 | 0002037804-26-000015 |
Related borrowers
Same lenders